Beijing Institute for Brain Disorders, Advanced Innovation Center for Human Brain Protection, National Clinical Research Center for Geriatric Disorders, Xuanwu Hospital Capital Medical University, Beijing, China.
Key Laboratory of Genomics and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China.
Nat Rev Mol Cell Biol. 2020 Mar;21(3):137-150. doi: 10.1038/s41580-019-0204-5. Epub 2020 Feb 4.
Ageing is characterized by the functional decline of tissues and organs and the increased risk of ageing-associated disorders. Several 'rejuvenating' interventions have been proposed to delay ageing and the onset of age-associated decline and disease to extend healthspan and lifespan. These interventions include metabolic manipulation, partial reprogramming, heterochronic parabiosis, pharmaceutical administration and senescent cell ablation. As the ageing process is associated with altered epigenetic mechanisms of gene regulation, such as DNA methylation, histone modification and chromatin remodelling, and non-coding RNAs, the manipulation of these mechanisms is central to the effectiveness of age-delaying interventions. This Review discusses the epigenetic changes that occur during ageing and the rapidly increasing knowledge of how these epigenetic mechanisms have an effect on healthspan and lifespan extension, and outlines questions to guide future research on interventions to rejuvenate the epigenome and delay ageing processes.
衰老是指组织和器官功能下降以及与衰老相关疾病风险增加的特征。已经提出了几种“ rejuvenating ”干预措施来延缓衰老和与年龄相关的衰退和疾病的发生,以延长健康寿命和寿命。这些干预措施包括代谢操纵、部分重编程、异时共生、药物治疗和衰老细胞消融。由于衰老过程与基因调控的表观遗传机制改变有关,如 DNA 甲基化、组蛋白修饰和染色质重塑以及非编码 RNA,因此这些机制的操纵是延缓衰老干预措施有效性的核心。本综述讨论了衰老过程中发生的表观遗传变化,以及这些表观遗传机制如何影响健康寿命和寿命延长的知识迅速增加,并概述了指导未来干预措施研究以恢复表观基因组并延缓衰老过程的问题。